New drugs to treat tuberculosis

This publication has 35 references indexed in Scilit:

• Protease inhibitor-containing antiretroviral treatment and tuberculosis: can rifabutin fill the breach? [Review article]
  The International Journal of Tuberculosis and Lung Disease, 2012
• Pediatric Tuberculosis: Global Overview and Challenges
  Clinical Infectious Diseases, 2010
• Linezolid in the Treatment of Multidrug‐Resistant Tuberculosis
  Clinical Infectious Diseases, 2010
• Addition of PNU-100480 to First-Line Drugs Shortens the Time Needed to Cure Murine Tuberculosis
  American Journal of Respiratory and Critical Care Medicine, 2009
• The Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis
  New England Journal of Medicine, 2009
• Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial
  The Lancet, 2009
• A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis
  European Respiratory Journal, 2009
• Daily Dosing of Rifapentine Cures Tuberculosis in Three Months or Less in the Murine Model
  PLOS Medicine, 2007
• Moxifloxacin versus Ethambutol in the First 2 Months of Treatment for Pulmonary Tuberculosis
  American Journal of Respiratory and Critical Care Medicine, 2006
• Pharmacokinetics-Pharmacodynamics of Rifampin in an Aerosol Infection Model of Tuberculosis
  Antimicrobial Agents and Chemotherapy, 2003